|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Restricted stock units | (1) | 07/13/2018 | A | 1,959 | (2) | (2) | Cyanotech common stock | 1,959 | $ 0 | 1,959 | D | ||||
Restricted stock units | (1) | (3) | (3) | Cyanotech common stock | 67 | 67 | D | ||||||||
Cyanotech common stock options | $ 3.35 | (4) | 07/14/2027 | Cyanotech common stock | 75,000 | 75,000 | D | ||||||||
Cyanotech common stock options | $ 3.83 | (5) | 01/24/2028 | Cyanotech common stock | 45,000 | 45,000 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Morton Mawae 73-4460 QUEEN KAAHUMANU HWY #102 KAILUA-KONA, HI 96740 |
X | CEO |
/s/ Dan Sprague, by Power of Attorney | 07/18/2018 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. |
(2) | The restricted stock units shall vest as to 653 shares on July 13, 2019, 653 shares on July 13, 2020, and 653 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. |
(3) | The restricted stock units shall vest as to 33 shares on April 5, 2019 and 34 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. |
(4) | The stock options shall vest as to 25,000 shares on July 14, 2018, 25,000 shares on July 14, 2019 and 25,000 shares on July 14, 2020, in each case subject to continued service with Cyanotech on the vesting date. |
(5) | The stock options shall vest as to 15,000 shares on January 24, 2019, 15,000 shares on January 24, 2020 and 15,000 shares on January 24, 2021, in each case subject to continued service with Cyanotech on the vesting date. |